Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
International Journal for Parasitology. Drugs and Drug Resistance
|
May 24, 2021
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts
Dennis Imhof, Nicoleta Anghel, Pablo Winzer, et al.
Experimental Parasitology
|
January 10, 2017
Extended-spectrum antiprotozoal bumped kinase inhibitors: A review
Wesley C Van Voorhis, J Stone Doggett, Marilyn Parsons, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
The Journal of Experimental Medicine
|
June 9, 2016
Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone
Lauren A Lawres, Aprajita Garg, Vidya Kumar, et al.
Journal of Medicinal Chemistry
|
April 12, 2014
Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers
Aaron Nilsen, Galen P Miley, Isaac P Forquer, et al.
ACS Infectious Diseases
|
June 11, 2024
3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance
Sovitj Pou, Rolf W Winter, Rozalia A Dodean, et al.
Journal of Medicinal Chemistry
|
June 10, 2026
Revisiting 2-Substituted-4(1<i>H</i>)-Quinolones for Targeting the <i>Plasmodium falciparum</i> Cytochrome bc<sub>1</sub> Complex
Sovitj Pou, Katherine M Liebman, Rolf W Winter, et al.
Journal of Medicinal Chemistry
|
June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis
Rama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
ACS Medicinal Chemistry Letters
|
December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1
Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Veterinary Parasitology
|
January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases
Wesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
International Journal for Parasitology. Drugs and Drug Resistance
|
May 24, 2021
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts
Dennis Imhof, Nicoleta Anghel, Pablo Winzer, et al.
Experimental Parasitology
|
January 10, 2017
Extended-spectrum antiprotozoal bumped kinase inhibitors: A review
Wesley C Van Voorhis, J Stone Doggett, Marilyn Parsons, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
The Journal of Experimental Medicine
|
June 9, 2016
Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone
Lauren A Lawres, Aprajita Garg, Vidya Kumar, et al.
Journal of Medicinal Chemistry
|
April 12, 2014
Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers
Aaron Nilsen, Galen P Miley, Isaac P Forquer, et al.
ACS Infectious Diseases
|
June 11, 2024
3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance
Sovitj Pou, Rolf W Winter, Rozalia A Dodean, et al.
Journal of Medicinal Chemistry
|
June 10, 2026
Revisiting 2-Substituted-4(1<i>H</i>)-Quinolones for Targeting the <i>Plasmodium falciparum</i> Cytochrome bc<sub>1</sub> Complex
Sovitj Pou, Katherine M Liebman, Rolf W Winter, et al.
Journal of Medicinal Chemistry
|
June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis
Rama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
ACS Medicinal Chemistry Letters
|
December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1
Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Veterinary Parasitology
|
January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases
Wesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
Page
of 5